Cargando…
Mesenchymal Stem/Stromal Cells: PRELIMINARY RESULTS FOR THE CELLULAR IMMUNO-THERAPY FOR COVID-19-RELATED ARDS MULTICENTRE CANADIAN RANDOMIZED CLINICAL TRIAL: CIRCA-19 PHASE 2 RCT
Autores principales: | Stewart, D.J., English, S., Fergusson, D., Soliman, K., Chassé, M., Lalu, M., Thebaud, B., Watpool, I., Champagne, J., Courtman, D.W., Khan, S., Hodgins, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society for Cell & Gene Therapy. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171027/ http://dx.doi.org/10.1016/S1465-3249(23)00177-9 |
Ejemplares similares
-
Results of the cellular immuno-therapy for covid-19 related acute respiratory distress syndrome (circa-phase i trial
por: English, S., et al.
Publicado: (2021) -
Mesenchymal Stem/Stromal Cells: ON DEMAND MANUFACTURING STRATEGY TO DELIVER MULTIPLE DOSES OF FRESHLY CULTURED UMBILICAL CORD DERIVED MSCS IN THE CELLULAR IMMUNO-THERAPY FOR COVID-19 RELATED ARDS CLINICAL TRIAL
por: Khan, S., et al.
Publicado: (2023) -
Foodborne Illness, Australia, Circa 2000 and Circa 2010
por: Kirk, Martyn, et al.
Publicado: (2014) -
Pain and Surgery in England, circa 1620–circa 1740
por: Walker, Katherine A.
Publicado: (2015) -
Pulmonary immuno-thrombosis in COVID-19 ARDS pathogenesis
por: O’Donnell, James S., et al.
Publicado: (2021)